DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang SR | - |
dc.contributor.author | Kim, Jong Duk | - |
dc.contributor.author | Kim SB | - |
dc.contributor.author | Park J | - |
dc.contributor.author | Joe CO | - |
dc.date.accessioned | 2016-06-28T03:53:54Z | - |
dc.date.available | 2016-06-28T03:53:54Z | - |
dc.date.created | 2016-03-24 | - |
dc.date.issued | 2004-06-12 | - |
dc.identifier.citation | The 31st annual Meeting and Exposition of the controlled release society | - |
dc.identifier.uri | http://hdl.handle.net/10203/208265 | - |
dc.language | English | - |
dc.publisher | controlled release society | - |
dc.title | Oligoarginine conjugated poly (2-hydroxyethyl aspartamide) as a novel intracellular delivery carrier of anticancer drugs | - |
dc.type | Conference | - |
dc.type.rims | CONF | - |
dc.citation.publicationname | The 31st annual Meeting and Exposition of the controlled release society | - |
dc.identifier.conferencecountry | US | - |
dc.contributor.localauthor | Kim, Jong Duk | - |
dc.contributor.nonIdAuthor | Yang SR | - |
dc.contributor.nonIdAuthor | Kim SB | - |
dc.contributor.nonIdAuthor | Park J | - |
dc.contributor.nonIdAuthor | Joe CO | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.